Surmont VF[au] - Search Results

Year	Number of Results
2002	1
2005	1
2006	1
2009	1
2010	1
2011	5
2013	1
2014	1
2015	2
2016	1
2018	1
2022	1
2023	1
2024	0

1

Surmont VF, van Meerbeeck JP. Surmont VF, et al. Expert Rev Anticancer Ther. 2011 Oct;11(10):1481-90. doi: 10.1586/era.11.136. Expert Rev Anticancer Ther. 2011. PMID: 21999120 Review.

2

Management of malignant pleural mesothelioma: have we made any progress?

Hiddinga BI, Surmont VF, Van Meerbeeck JP. Hiddinga BI, et al. Among authors: surmont vf. Panminerva Med. 2013 Jun;55(2):157-73. Panminerva Med. 2013. PMID: 23676957 Review.

3

Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

Vanfleteren MJEGW, Dingemans AC, Surmont VF, Vermaelen KY, Postma AA, Oude Lashof AML, Pitz CCM, Hendriks LEL. Vanfleteren MJEGW, et al. Among authors: surmont vf. Front Oncol. 2018 Jun 5;8:188. doi: 10.3389/fonc.2018.00188. eCollection 2018. Front Oncol. 2018. PMID: 29922593 Free PMC article.

4

Investigational approaches for mesothelioma.

Surmont VF, van Thiel ER, Vermaelen K, van Meerbeeck JP. Surmont VF, et al. Front Oncol. 2011 Aug 22;1:22. doi: 10.3389/fonc.2011.00022. eCollection 2011. Front Oncol. 2011. PMID: 22666659 Free PMC article.

5

Malignant pleural mesothelioma: when is radiation therapy indicated?

van Thiel ER, Surmont VF, van Meerbeeck JP. van Thiel ER, et al. Among authors: surmont vf. Expert Rev Anticancer Ther. 2011 Apr;11(4):551-60. doi: 10.1586/era.10.169. Expert Rev Anticancer Ther. 2011. PMID: 21504322 Review.

6

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma.

Janssens E, Schillebeeckx E, Zwijsen K, Raskin J, Van Cleemput J, Surmont VF, Nackaerts K, Marcq E, van Meerbeeck JP, Lamote K. Janssens E, et al. Among authors: surmont vf. Cancers (Basel). 2022 Jun 29;14(13):3182. doi: 10.3390/cancers14133182. Cancers (Basel). 2022. PMID: 35804954 Free PMC article.

7

Malignant pleural mesothelioma: the standard of care and challenges for future management.

van Meerbeeck JP, Scherpereel A, Surmont VF, Baas P. van Meerbeeck JP, et al. Among authors: surmont vf. Crit Rev Oncol Hematol. 2011 May;78(2):92-111. doi: 10.1016/j.critrevonc.2010.04.004. Epub 2010 May 13. Crit Rev Oncol Hematol. 2011. PMID: 20466560 Review.

8

Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.

van Meerbeeck JP, Surmont VF. van Meerbeeck JP, et al. Among authors: surmont vf. Lung Cancer. 2009 Sep;65(3):257-67. doi: 10.1016/j.lungcan.2009.02.007. Epub 2009 Mar 13. Lung Cancer. 2009. PMID: 19285751 Review.

9

Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.

Zwijsen K, Schillebeeckx E, Janssens E, Cleemput JV, Richart T, Surmont VF, Nackaerts K, Marcq E, van Meerbeeck JP, Lamote K. Zwijsen K, et al. Among authors: surmont vf. J Breath Res. 2023 Sep 21;17(4). doi: 10.1088/1752-7163/acf7e3. J Breath Res. 2023. PMID: 37683624

10

Unexpected response of a pulmonary blastoma on radiotherapy: a case report and review of the literature.

Surmont VF, van Klaveren RJ, Nowak PJ, Zondervan PE, Hoogsteden HC, van Meerbeeck JP. Surmont VF, et al. Lung Cancer. 2002 May;36(2):207-11. doi: 10.1016/s0169-5002(01)00465-2. Lung Cancer. 2002. PMID: 11955657 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year